These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12394076)

  • 1. The overactive bladder: a nursing perspective.
    Newman DK; Giovannini D
    Am J Nurs; 2002 Jun; 102(6):36-45; quiz 46. PubMed ID: 12394076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overactive bladder. Strategies for better recognition and management.
    Smith DA
    Adv Nurse Pract; 2004 Mar; 12(3):26-33; quiz 34. PubMed ID: 15038182
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of overactive bladder: the Antimuscarinic Clinical Effectiveness Trial.
    Appell RA
    Curr Urol Rep; 2002 Oct; 3(5):343-4. PubMed ID: 12354340
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder.
    Abrams P; Freeman R; Anderström C; Mattiasson A
    Br J Urol; 1998 Jun; 81(6):801-10. PubMed ID: 9666761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and management of urinary incontinence.
    Gray M
    Nurse Pract; 2005 Jul; 30(7):32-3, 36-43; quiz 43-5. PubMed ID: 16021028
    [No Abstract]   [Full Text] [Related]  

  • 6. New treatment options for overactive bladder and incontinence.
    Newman DK
    Director; 2002; 10(3):74-6. PubMed ID: 12116753
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic treatment for detrusor overactivity.
    Lai HH; Boone TB; Appell RA
    Curr Urol Rep; 2002 Oct; 3(5):365-72. PubMed ID: 12354344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on drugs for overactive bladder syndrome.
    Drug Ther Bull; 2007 Jun; 45(6):44-8. PubMed ID: 17583229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity.
    Guay DR
    Pharmacotherapy; 1999 Mar; 19(3):267-80. PubMed ID: 10221366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolterodine.
    Hills CJ; Winter SA; Balfour JA
    Drugs; 1998 Jun; 55(6):813-20; discussion 821-2. PubMed ID: 9617596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis.
    Appell RA
    Urology; 1997 Dec; 50(6A Suppl):90-6; discussion 97-9. PubMed ID: 9426760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving bladder control. Treatment in the primary care setting.
    Maloney CM; Cafiero M
    Adv Nurse Pract; 2002 May; 10(5):73-8. PubMed ID: 12420535
    [No Abstract]   [Full Text] [Related]  

  • 13. Tolterodine: a safe and effective treatment for older patients with overactive bladder.
    Malone-Lee JG; Walsh JB; Maugourd MF
    J Am Geriatr Soc; 2001 Jun; 49(6):700-5. PubMed ID: 11454106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overactive bladder: recognition requires vigilance for symptoms.
    Rosenberg MT; Newman DK; Tallman CT; Page SA
    Cleve Clin J Med; 2007 May; 74 Suppl 3():S21-9. PubMed ID: 17546830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overactive bladder: evaluation and management in primary care.
    Rosenberg MT; Dmochowski RR
    Cleve Clin J Med; 2005 Feb; 72(2):149-56. PubMed ID: 15757170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detrol LA and Diropan XL for overactive bladder.
    Med Lett Drugs Ther; 2001 Apr; 43(1101):28. PubMed ID: 11283473
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experiences with tolterodine.
    Nilvebrant L
    Life Sci; 2001 Apr; 68(22-23):2549-56. PubMed ID: 11392625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which anticholinergic drug for overactive bladder symptoms in adults.
    Hay-Smith J; Herbison P; Ellis G; Morris A
    Cochrane Database Syst Rev; 2005 Jul; (3):CD005429. PubMed ID: 16034974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern pharmacotherapy of urge urinary incontinence in the USA: tolterodine and oxybutynin.
    Rovner ES; Wein AJ
    BJU Int; 2000 Oct; 86 Suppl 2():44-53; discussion 53-4. PubMed ID: 11501617
    [No Abstract]   [Full Text] [Related]  

  • 20. Current pharmacotherapeutic strategies for overactive bladder.
    Garely AD; Burrows LJ
    Expert Opin Pharmacother; 2002 Jul; 3(7):827-33. PubMed ID: 12083983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.